Guidance for expanded use of oseltamivir (Tamiflu®) in children under one year of age in the context of Pandemic (H1N1) 2009
This guidance has been updated based on current scientific evidence, expert opinion and the Interim Order, issued by the Federal Minister of Health, permitting the expanded use of oseltamivir for the influenza A H1N1 virus in children under 1 year of age
Guidance: Infection Prevention and Control Measures for Occupational Health Management for all Health Care Settings
This guidance document has been developed to provide guidance for the occupational health (OH) and infection prevention and control (IPC) management of health care workers (HCWs) and other staff to prevent the transmission of Pandemic (H1N1) 2009 Flu Virus in all settings where health care is provided.
The Honourable Leona Aglukkaq, federal Minister of Health, along with Dr. David Butler-Jones, Chief Public Health Officer of Canada, and Dr. Danielle Grondin, Infectious Disease and Emergency Preparedness at the Public Health Agency of Canada, will provide an update on the H1N1 flu virus.
Guidance for Remote and Isolated (RI) Communities in the context of the pandemic (H1N1) 2009 outbreak
This document can be used by community health planners, public health departments, regional health authorities and the provinces and territories, as well as health care providers who work with remote and isolated communities.
Top quality health care is central to ensuring Montreal remains a leading international city that offers an enhanced quality of life.
An innovative treatment for HIV/AIDS patients developed by McGill University Health Centre (MUHC) researchers has passed its first clinical trial with flying colours.
The McGill University Health Centre is proud to announce the exceptional contributions of nine employees and one team as part of the first annual MUHC Director General’s Awards
Community leaders including Lachine Mayor Claude Dauphin will participate tomorrow in the launch of the Lachine Hospital Foundation’s most ambitious campaign in its history.
This statement provides a summary of the epidemiology of pandemic H1N1 human influenza (pH1N1), as well as information on the pH1N1 vaccines approved for use in Canada and their recommended usage.